SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $643,000 | +21.1% | 25,563 | +0.3% | 0.14% | -2.8% |
| Q3 2020 | $531,000 | -12.4% | 25,499 | 0.0% | 0.14% | -8.4% |
| Q2 2020 | $606,000 | +60.3% | 25,499 | +21.3% | 0.15% | +32.8% |
| Q1 2020 | $378,000 | -24.2% | 21,027 | 0.0% | 0.12% | +24.7% |
| Q4 2019 | $499,000 | -16.8% | 21,027 | -3.7% | 0.09% | -29.0% |
| Q3 2019 | $600,000 | -31.7% | 21,839 | -17.7% | 0.13% | -28.4% |
| Q2 2019 | $878,000 | -5.7% | 26,539 | -0.1% | 0.18% | -7.1% |
| Q1 2019 | $931,000 | +3.0% | 26,561 | -2.4% | 0.20% | -8.4% |
| Q4 2018 | $904,000 | -48.6% | 27,219 | -22.1% | 0.22% | -37.9% |
| Q3 2018 | $1,760,000 | -16.8% | 34,961 | -1.1% | 0.35% | -19.9% |
| Q2 2018 | $2,116,000 | +21.1% | 35,361 | -7.3% | 0.43% | +16.8% |
| Q1 2018 | $1,748,000 | +130.0% | 38,161 | +100.2% | 0.37% | +74.5% |
| Q4 2017 | $760,000 | -0.3% | 19,061 | 0.0% | 0.21% | -2.3% |
| Q3 2017 | $762,000 | +32.3% | 19,061 | +42.7% | 0.22% | +52.8% |
| Q2 2017 | $576,000 | +37.8% | 13,361 | 0.0% | 0.14% | +43.4% |
| Q1 2017 | $418,000 | +24.0% | 13,361 | 0.0% | 0.10% | +17.9% |
| Q4 2016 | $337,000 | +45.3% | 13,361 | -22.7% | 0.08% | +35.5% |
| Q4 2015 | $232,000 | -4.1% | 17,278 | 0.0% | 0.06% | +19.2% |
| Q3 2015 | $242,000 | -86.0% | 17,278 | -83.0% | 0.05% | -83.5% |
| Q2 2015 | $1,725,000 | +172400.0% | 101,578 | +158615.6% | 0.32% | – |
| Q1 2015 | $1,000 | 0.0% | 64 | -31.9% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 94 | -14.5% | 0.00% | – |
| Q3 2014 | $1,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |